Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 Clinical Trial to Investigate Nu-3 Antimicrobial for the Treatment of Chronic Diabetic Foot Ulcers (cDFU) in the Bahamas

Next Previous
Search
Trial Profile

A Phase 2 Clinical Trial to Investigate Nu-3 Antimicrobial for the Treatment of Chronic Diabetic Foot Ulcers (cDFU) in the Bahamas

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 24 Jan 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nu 3 (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors Lakewood Amedex

    • Most Recent Events

    • 24 Jan 2019 New trial record
    • 17 Jan 2019 According to a Lakewood Amedex media release, the company had entered into a collaboration agreement with Nassau based Foot and Ankle International (Bahamas) to conduct this trial.The trial will be under the direction of the prominent Bahamian surgeon, Dr. Daniel Johnson, who is the principal and chief researcher of Foot and Ankle International (Bahamas).
    • 17 Jan 2019 According to a Lakewood Amedex media release, the company intend to conduct this trial commencing early 2019.Lake-Amedex also intends to conduct an 'adaptive arm' of this clinical trial which will involve treating an increased number of patients with the most effective concentration of the gel formulation to achieve robust clinical data.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top